We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGTC
12801
PUT
DELISTED
Applied Genetic Technologies Corporation
AGTC
$98K ﹤0.01%
32,600
-20,500
-39% -$73K
AVAN.WS
12802
DELISTED
Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AVAN.WS
$98K ﹤0.01%
150,087
+87
+0.1% +$75
VTAQR
12803
DELISTED
Ventoux CCM Acquisition Corp. Right
VTAQR
$98K ﹤0.01%
562,736
-68,888
-11% -$14.4K
CRMD icon
12804
CorMedix
CRMD
$588M
$97K ﹤0.01%
20,833
-9,287
-31% -$54.1K
FPH icon
12805
CALL
Five Point Holdings
FPH
$371M
$97K ﹤0.01%
12,400
-8,700
-41% -$70.6K
FRSX
12806
CALL
Foresight Autonomous Holdings
FRSX
$3.87M
$97K ﹤0.01%
247
-163
-40% -$68.9K
LXRX icon
12807
PUT
Lexicon Pharmaceuticals
LXRX
$1.03B
$97K ﹤0.01%
20,200
-6,200
-23% -$25.4K
PANL icon
12808
CALL
Pangaea Logistics
PANL
$487M
$97K ﹤0.01%
+19,200
New +$94.2K
VOC icon
12809
CALL
VOC Energy
VOC
$53.9M
$97K ﹤0.01%
21,200
+6,500
+44% +$28.7K
BFI
12810
DELISTED
BurgerFi International, Inc. Common Stock
BFI
$97K ﹤0.01%
11,250
-35,310
-76% -$362K
PRTK
12811
PUT
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$97K ﹤0.01%
20,000
+1,100
+6% +$6.06K
INFI
12812
PUT
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$97K ﹤0.01%
28,300
+5,500
+24% +$17K
ACOR
12813
CALL
DELISTED
Acorda Therapeutics
ACOR
$97K ﹤0.01%
1,055
+510
+94% +$42.3K
BLCM
12814
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$97K ﹤0.01%
33,252
-365
-1% -$1.11K
PDOT.WS
12815
DELISTED
Peridot Acquisition Corp. II Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PDOT.WS
$97K ﹤0.01%
120,176
-1,853
-2% -$1.95K
MACC.WS
12816
DELISTED
Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
MACC.WS
$97K ﹤0.01%
166,666
-873
-0.5% -$610
VOSOW
12817
DELISTED
Virtuoso Acquisition Corp. Warrant
VOSOW
$97K ﹤0.01%
84,820
-468,917
-85% -$607K
ADTX
12818
PUT
DELISTED
ADITXT INC
ADTX
0
DHY
12819
Credit Suisse High Yield Credit Fund
DHY
$239M
$96K ﹤0.01%
+38,950
New +$97.8K
INOD icon
12820
CALL
Innodata
INOD
$2.09B
$96K ﹤0.01%
+10,100
New +$77.4K
OXSQ icon
12821
CALL
Oxford Square Capital
OXSQ
$157M
$96K ﹤0.01%
23,700
-3,600
-13% -$16.4K
RBBN icon
12822
Ribbon Communications
RBBN
$377M
$96K ﹤0.01%
16,105
-52,262
-76% -$353K
SVM
12823
CALL
Silvercorp Metals
SVM
$2.66B
$96K ﹤0.01%
25,300
-38,900
-61% -$176K
SXC icon
12824
CALL
SunCoke Energy
SXC
$794M
$96K ﹤0.01%
15,300
-10,700
-41% -$73.5K
DXYN
12825
CALL
DELISTED
Dixie Group Inc
DXYN
$96K ﹤0.01%
19,700
-9,300
-32% -$36.3K

Similar funds

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.